Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients

被引：9
作者：
Carvalho, Raimundo M. [2 ,3 ]
Pinto, Giovanny R. [1 ]
Yoshioka, France K. N. [1 ]
Lima, Patricia D. L. [3 ]
Souza, Carolina R. T. [3 ]
Guimaraes, Adriana C. [3 ]
Lamarao, Leticia M. [3 ]
Rey, Juan A. [4 ]
Burbano, Rommel R. [3 ]
机构：
[1] Univ Fed Piaui, Genet & Mol Biol Lab, BR-64202020 Parnaiba, PI, Brazil
[2] Ophir Loyola Hosp, Dept Neurosurg, BR-66063240 Belem, Para, Brazil
[3] Fed Univ Para, Human Cytogenet Lab, BR-66075110 Belem, Para, Brazil
[4] Hosp Univ La Paz, Unidad Invest, Res Unit, Madrid 28046, Spain
来源：
JOURNAL OF NEURO-ONCOLOGY | 2012年 / 110卷 / 01期
关键词：
Medulloblastomas; TP53 Arg72Pro SNP; Risk; Prognosis; Adjuvant therapy; CODON-72; POLYMORPHISM; P53; SURVIVAL; TUMOR; RISK; MYC; CLASSIFICATION; VARIANTS; CHILDREN; MUTATION;
D O I：
10.1007/s11060-012-0950-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Medulloblastoma is a highly cellular malignant embryonal neoplasm, being the most common malignant pediatric brain tumor, accounting for 20-25 % of pediatric central nervous system tumors. To investigate the effect of the TP53 Arg72Pro single-nucleotide polymorphism (SNP) on clinicopathological and phenotypic parameters, we performed a case-controlled study of 122 patients and 122 healthy controls from Brazil. No significant associations were found between the TP53 Arg72Pro genotypes and the clinicopathological parameters studied. Compared with Arg/Arg, which is the most common genotype in the study population, both the Arg/Pro and Pro/Pro genotypes did not influence the medulloblastoma development risk [odds ratio (OR) = 1.36 and P = 0.339 for the Arg/Pro genotype; OR = 1.50 and P = 0.389 for the Pro/Pro genotype]. With regard to prognosis, disease-free survival was not significantly different among the TP53 Arg72Pro SNP genotypes (P > 0.05), but the less frequent genotype (Pro/Pro) was associated with shorter overall survival of medulloblastoma patients (P = 0.021). These data suggest that, although there is no association between the TP53 Arg72Pro SNP and medulloblastoma risk, the Pro/Pro genotype is associated with shorter overall survival of patients submitted to adjuvant therapy. Nevertheless, due to the interethnic composition of the Brazilian population, future studies on larger populations from other parts of the world are essential for a definitive conclusion on the function of the TP53 Arg72Pro SNP.
引用
收藏
页码：49 / 57
页数：9
相关论文
共 40 条
[1]   Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors [J].
Almeida, L. O. ;
Custodio, C. ;
Pinto, G. R. ;
Santos, M. J. ;
Almeida, J. R. W. ;
Clara, C. A. ;
Rey, J. A. ;
Casartelli, C. .
GENETICS AND MOLECULAR RESEARCH, 2009, 8 (01) :8-18
[2]   TP53 family members and human cancers [J].
Bénard, J ;
Douc-Rasy, S ;
Ahomadegbe, JC .
HUMAN MUTATION, 2003, 21 (03) :182-191
[3]   Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients [J].
Biros, E ;
Kalina, I ;
Kohút, A ;
Bogyiová, E ;
Salagovic, J ;
Sulla, I .
PHYSIOLOGICAL RESEARCH, 2002, 51 (01) :59-64
[4]   Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET) [J].
Brandes, Alba A. ;
Franceschi, Enrico ;
Tosoni, Alicia ;
Reni, Michele ;
Gatta, Gemma ;
Vecht, Charles ;
Kortmann, Rolf D. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (02) :165-179
[5]   Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer [J].
Cerne, Jasmina-Ziva ;
Pohar-Perme, Maja ;
Novakovic, Srdjan ;
Frkovic-Grazio, Snjezana ;
Stegel, Vida ;
Gersak, Ksenija .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (02) :110-119
[6]   Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression [J].
de Haas, Talitha ;
Hasselt, Nancy ;
Troost, Dirk ;
Caron, Huib ;
Popovic, Mara ;
Zadravec-Zaletel, Lorna ;
Grajkowska, Wieslawa ;
Perek, Marta ;
Osterheld, Maria-Chiara ;
Ellison, David ;
Baas, Frank ;
Versteeg, Rogier ;
Kool, Marcel .
CLINICAL CANCER RESEARCH, 2008, 14 (13) :4154-4160
[7]   The codon 72 polymorphic variants of p53 have markedly different apoptotic potential [J].
Dumont, P ;
Leu, JIJ ;
Della Pietra, AC ;
George, DL ;
Murphy, M .
NATURE GENETICS, 2003, 33 (03) :357-365
[8]   Histopathologic grading of medulloblastomas - A pediatric oncology group study [J].
Eberhart, CG ;
Kepner, JL ;
Goldthwaite, PT ;
Kun, LE ;
Duffner, PK ;
Friedman, HS ;
Strother, DR ;
Burger, PC .
CANCER, 2002, 94 (02) :552-560
[9]   p53: Guardian of the genome and policeman of the oncogenes [J].
Efeyan, Alejo ;
Serrano, Manuel .
CELL CYCLE, 2007, 6 (09) :1006-1010
[10]   TP53 codon 72 polymorphism is associated with age at onset of glioblastoma [J].
El Hallani, S. ;
Ducray, F. ;
Idbaih, A. ;
Marie, Y. ;
Boisselier, B. ;
Colin, C. ;
Laigle-Donadey, F. ;
Rodero, M. ;
Chinot, O. ;
Thillet, J. ;
Hoang-Xuan, K. ;
Delattre, J. -Y. ;
Sanson, M. .
NEUROLOGY, 2009, 72 (04) :332-336
1234